Le Lézard
Classified in: Health, Science and technology, Business
Subject: ANW

Ackerman Group's Founder Dr. Gary Ackerman Featured In Podcast Advising Veterinarians In Selling Their Practice


RICHMOND, Va., Aug. 24, 2021 /PRNewswire/ -- Dr. Gary Ackerman, a leader in veterinary business transitions and founder of Ackerman Group, recently joined Dr. Ivan Zak and Ryan Leech of Veterinary Integration Solutions for their podcast ? Consolidate That! which focuses on critical topics in the veterinary business.

You can listen to the full 28-minute podcast here, ackerman-group.com/resources/traffic-ahead-roadblocks-to-selling-a-practice/.

In this episode, "Traffic Ahead: Roadblocks to Selling a Practice", Dr. Ackerman discusses possible pitfalls practice owners may encounter when selling their practice and what to avoid. Dr. Gary Ackerman has been advising veterinary practice owners on successfully transitioning their practice for over 20 years and has completed over $1.5 billion in veterinary tax deferred transactions as well as over $800 million in practice sales.

Dr. Ackerman discusses the importance of finding the right help when selling and how to best position yourself and your practice to potential buyers. He continues with how to get the process of selling started and wants practice owners to understand what options they have for the best possible outcome for their future and the future of the practice.

When asked what is the biggest thing that can go wrong, he said, "The biggest thing that can go wrong ? doing it yourself. These are much more complex transactions than 5 years ago." Dr. Ackerman also discusses the state of the market and the current interest in veterinary hospitals along with practice structures that include joint ventures and private equity. 

For more educational resources on selling your veterinary practice visit, Ackerman Group's Learning Center, ackerman-group.com/knowledge-base/learning-resources/

About Ackerman Group

Ackerman Group educates and guides veterinary practice owners through the complex business transition process to secure the best fit for their practice culture, personalized terms, and maximum value for their most important asset: their practice. Ackerman Group provides no cost, no obligation eValuation of qualifying veterinary practices to help every owner understand where their practice stands in the marketplace with similar sized practices.

Since 2018 Ackerman Group has completed over $800 million in veterinary practices sales to corporate buyers. Through a holistic approach, Ackerman Group has created a highly effective process helping practice owners make the best decisions for their practice, and employees and their future.

SOURCE Ackerman Group


These press releases may also interest you

at 07:05
Intevac, Inc. today reported financial results for the first quarter ended March 30, 2024. Q1 Highlights: Continued strong demand for technology upgrades for hard disk drive (HDD) media resulted in sales of nearly $10 million and gross margin...

at 07:05
TelevisaUnivision, the world's leading Spanish-language media and content company, today announced financial results for the first quarter ended March 31, 2024. Please visit the company's Investor Relations website at investors.televisaunivision.com...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
LSI Industries Inc. a leading U.S. based manufacturer of commercial lighting and display solutions, today reported financial results for the fiscal 2024 third quarter ended March 31, 2024. FISCAL 2024 THIRD QUARTER RESULTS Net Sales of $108.2...

at 07:05
LiveWire Group, Inc. ("LiveWire" or the "Company") today reported first quarter 2024 results. "We are pleased with the successful launch of the S2 Mulholland, and with three bikes in market, we are proud that LiveWire is now the #1 on-road...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...



News published on and distributed by: